ATE497776T1 - Nicht-hypertensive pegylierte hämoglobine und deren herstellungsverfahren - Google Patents

Nicht-hypertensive pegylierte hämoglobine und deren herstellungsverfahren

Info

Publication number
ATE497776T1
ATE497776T1 AT03799982T AT03799982T ATE497776T1 AT E497776 T1 ATE497776 T1 AT E497776T1 AT 03799982 T AT03799982 T AT 03799982T AT 03799982 T AT03799982 T AT 03799982T AT E497776 T1 ATE497776 T1 AT E497776T1
Authority
AT
Austria
Prior art keywords
hypertensive
production
peg chains
reacting
bound
Prior art date
Application number
AT03799982T
Other languages
English (en)
Inventor
Seetharama Acharya
Belur Manjula
Original Assignee
Einstein Coll Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Einstein Coll Med filed Critical Einstein Coll Med
Application granted granted Critical
Publication of ATE497776T1 publication Critical patent/ATE497776T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
AT03799982T 2002-12-23 2003-12-18 Nicht-hypertensive pegylierte hämoglobine und deren herstellungsverfahren ATE497776T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43614902P 2002-12-23 2002-12-23
PCT/US2003/040407 WO2004058291A1 (en) 2002-12-23 2003-12-18 Modified hemoglobin and methods of making same

Publications (1)

Publication Number Publication Date
ATE497776T1 true ATE497776T1 (de) 2011-02-15

Family

ID=32682349

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03799982T ATE497776T1 (de) 2002-12-23 2003-12-18 Nicht-hypertensive pegylierte hämoglobine und deren herstellungsverfahren

Country Status (16)

Country Link
US (1) US7501499B2 (de)
EP (1) EP1585538B1 (de)
JP (1) JP2006514652A (de)
KR (1) KR101086138B1 (de)
CN (1) CN1741812B (de)
AT (1) ATE497776T1 (de)
AU (1) AU2003299700B2 (de)
BR (1) BR0317721A (de)
CA (1) CA2511494A1 (de)
DE (1) DE60336018D1 (de)
ES (1) ES2360215T3 (de)
MX (1) MXPA05006702A (de)
MY (1) MY135256A (de)
SA (1) SA04250032B1 (de)
TW (1) TW200505941A (de)
WO (1) WO2004058291A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030153491A1 (en) * 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
SI1465643T1 (sl) * 2002-01-11 2008-06-30 Sangart Inc Postopki in sestavki za transport kisika z visokoafiniteto za kisik
US7144989B2 (en) 2002-03-25 2006-12-05 Albert Einstein College Of Medicine Of Yeshiva University Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof
US7521174B2 (en) * 2003-12-05 2009-04-21 Albert Einstein College Of Medicine Of Yeshiva University Universal red blood cells, methods of preparing same, and uses thereof
ES2347805T3 (es) * 2004-08-31 2010-11-04 Sangart, Inc. Metodos para aumentar la estabilidad hemodinamica usando composiciones que transportan oxigeno.
US20060134694A1 (en) * 2004-12-22 2006-06-22 Intel Corporation Methods of protein profiling by thiolation
CA2600927C (en) 2005-03-07 2017-04-18 Sangart, Inc. Compositions and methods for delivering carbon monoxide (co) and nitric oxide (no) to tissue using heme proteins as carriers
US20090215670A1 (en) * 2005-05-11 2009-08-27 Acharya Seetharama A Site specific pegylated hemoglobin, method of preparing same, and uses thereof
US8071546B2 (en) 2005-06-10 2011-12-06 La Jolla Bioengineering Institute Uses of pegylated albumin
US8741832B2 (en) * 2005-06-10 2014-06-03 Albert Einstein College Of Medicine Of Yeshiva University Pegylated albumin and uses thereof
US7795401B2 (en) * 2006-09-06 2010-09-14 National Chung Cheng University Modified hemoglobin with allosteric effector conjugated
US8697645B2 (en) * 2007-03-13 2014-04-15 Albert Einstein College Of Medicine Of Yeshiva University Second generation low oxygen affinity pegylated hemoglobins as oxygen-carrying plasma expanders
CN101306196B (zh) * 2008-07-03 2011-05-11 中国科学院长春应用化学研究所 一种生物降解的键合了血红蛋白分子的纳米粒子及制法
US10172949B2 (en) 2009-06-09 2019-01-08 Prolong Pharmaceuticals, LLC Hemoglobin compositions
PT2440239T (pt) 2009-06-09 2017-10-19 Prolong Pharmaceuticals Llc Composições de hemoglobina
US10172950B2 (en) 2009-06-09 2019-01-08 Prolong Pharmaceuticals, LLC Hemoglobin compositions
WO2011106396A1 (en) * 2010-02-25 2011-09-01 Sangart, Inc. Methods for preparing peg-hemoglobin conjugates using reduced reactant ratios
US7989593B1 (en) 2010-05-27 2011-08-02 Bing Lou Wong Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof
US7932356B1 (en) 2010-06-23 2011-04-26 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition
US8048856B1 (en) 2010-06-23 2011-11-01 Billion King, Ltd. Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition
US8084581B1 (en) 2011-04-29 2011-12-27 Bing Lou Wong Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
US20130052232A1 (en) 2011-08-31 2013-02-28 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking
CN109731098A (zh) 2012-03-29 2019-05-10 桑加特公司 双阿司匹林交联聚乙二醇化血红蛋白
CA2908238C (en) 2012-04-03 2023-01-10 Schindler, William Succinimide-activated nitroxyl compounds and methods for the use thereof for nitroxylation of proteins
KR102238718B1 (ko) 2013-03-15 2021-04-12 쉰들러, 윌리엄 폴리알킬렌 산화물 발레르산염 헤모글로빈 접합체

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234903A (en) * 1989-11-22 1993-08-10 Enzon, Inc. Chemically modified hemoglobin as an effective, stable non-immunogenic red blood cell substitute
US5585484A (en) * 1995-04-19 1996-12-17 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Hemoglobin crosslinkers
US5900402A (en) * 1997-05-29 1999-05-04 Enzon, Inc. Method of reducing side effects associated with administration of oxygen-carrying proteins
US6773613B1 (en) * 1998-10-15 2004-08-10 Sangart, Inc. Method for production of stroma-free hemoglobin
WO2003008932A2 (en) 2001-07-19 2003-01-30 Albert Einstein College Of Medecine Of Yeshiva University Size enhanced hemoglobins: surface decoration and crosslinking of the protein with polyoxy akylene glycols
US20030153491A1 (en) * 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
AU2003207503A1 (en) * 2002-01-11 2003-07-30 Sangart, Inc. Methods and compositions for oxygen transport comprising modified hemoglobin in plasma
US7144989B2 (en) * 2002-03-25 2006-12-05 Albert Einstein College Of Medicine Of Yeshiva University Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof
US7521174B2 (en) * 2003-12-05 2009-04-21 Albert Einstein College Of Medicine Of Yeshiva University Universal red blood cells, methods of preparing same, and uses thereof
US20090215670A1 (en) 2005-05-11 2009-08-27 Acharya Seetharama A Site specific pegylated hemoglobin, method of preparing same, and uses thereof

Also Published As

Publication number Publication date
CA2511494A1 (en) 2004-07-15
KR101086138B1 (ko) 2011-11-25
US7501499B2 (en) 2009-03-10
DE60336018D1 (de) 2011-03-24
AU2003299700B2 (en) 2009-03-26
TW200505941A (en) 2005-02-16
EP1585538A1 (de) 2005-10-19
EP1585538B1 (de) 2011-02-09
EP1585538A4 (de) 2007-11-21
KR20050084460A (ko) 2005-08-26
SA04250032B1 (ar) 2007-07-31
CN1741812B (zh) 2013-04-24
US20060135753A1 (en) 2006-06-22
AU2003299700A1 (en) 2004-07-22
JP2006514652A (ja) 2006-05-11
WO2004058291A1 (en) 2004-07-15
MY135256A (en) 2008-03-31
CN1741812A (zh) 2006-03-01
ES2360215T3 (es) 2011-06-01
BR0317721A (pt) 2005-12-06
MXPA05006702A (es) 2005-09-30

Similar Documents

Publication Publication Date Title
ATE497776T1 (de) Nicht-hypertensive pegylierte hämoglobine und deren herstellungsverfahren
DK1712547T3 (da) Bicycloesterderivat
BRPI0413323A (pt) processo para a preparação de vacinas conjugadas de polissacarìdeo-proteìna
WO1998001158A3 (de) Hämoglobin-hydroxyethylstärke-konjugate als sauerstoff-transport-mittel
CY1114922T1 (el) Κυτταροτοξικοι παραγοντες οι οποιοι περιλαμβανουν νεα παραγωγα τομαϋμυκινης και τη θεραπευτικη τους χρηση
ATE368066T1 (de) Hydrophiles polymerderivat mit y-verzweigung und herstellungsverfahren dafür; obige verbindung enthaltender medizinischer verbundwerkstoff
EP2292636A3 (de) Prozess, um Antikörper und therapeutische Produkte zu konzentrieren
FI942075A (fi) Sappihappojohdannaisten tetratsolijohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina
WO2005004809A3 (en) Multivalent carriers of bi-specific antibodies
MXPA05008938A (es) Quetoaldehidos macromoleculares.
WO2006134148A3 (en) Transglutaminase mediated conjugation of growth hormone
WO2002008190A3 (de) Neue heteroaryl-derivate und deren verwendung als antitumormittel
WO2008076270A3 (en) Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof
DE60137525D1 (de) Peg-modifiziertes erythropoietin
BR0214884A (pt) Derivados de 7-amino-benzotiazol como ligantes do receptor de adenosina
DK1503800T3 (da) Behandling og forebyggelse af vævsskade associeret med forøget C-reaktiv-protein produktion
DE602005026182D1 (de) Herstellung von insulinkonjugaten
FR2831534B1 (fr) Composition photoactivable et utilisations
WO2008016682A3 (en) Aryl vinyl sulfides, sulfones, sulfoxides and sulfonamides, derivatives thereof and therapeutic uses thereof
ATE359827T1 (de) Prozess für die vorbereitung von piroxicam: beta- cyclodextrin einschlusskomplexe
DE60021305D1 (de) Verfahren zur Herstellung von Diaminodiphenylmethan und seiner höheren Homologen
DE602005004154D1 (de) Bifunktionale derivate von polyethylenglykol, ihre herstellung und verwendung
DK1557387T3 (da) Transportorgan med en ledkæde og klemmer
EP1073623A4 (de) Substitutierte aminosaeuren als erythropoietin-mimetica
ATE446952T1 (de) Herstellungsverfahren von 2-cyanopyridinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties